1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Antiparasitic 1.2.3 Biological Products 1.2.4 Antibacterial 1.2.5 Others 1.3 Market by Application 1.3.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Prevention 1.3.3 Treatment 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pet Biopharmaceuticals Market Perspective (2017-2028) 2.2 Pet Biopharmaceuticals Growth Trends by Region 2.2.1 Pet Biopharmaceuticals Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Pet Biopharmaceuticals Historic Market Size by Region (2017-2022) 2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Region (2023-2028) 2.3 Pet Biopharmaceuticals Market Dynamics 2.3.1 Pet Biopharmaceuticals Industry Trends 2.3.2 Pet Biopharmaceuticals Market Drivers 2.3.3 Pet Biopharmaceuticals Market Challenges 2.3.4 Pet Biopharmaceuticals Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pet Biopharmaceuticals Players by Revenue 3.1.1 Global Top Pet Biopharmaceuticals Players by Revenue (2017-2022) 3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2017-2022) 3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Pet Biopharmaceuticals Revenue 3.4 Global Pet Biopharmaceuticals Market Concentration Ratio 3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2021 3.5 Pet Biopharmaceuticals Key Players Head office and Area Served 3.6 Key Players Pet Biopharmaceuticals Product Solution and Service 3.7 Date of Enter into Pet Biopharmaceuticals Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pet Biopharmaceuticals Breakdown Data by Type 4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2017-2022) 4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2023-2028) 5 Pet Biopharmaceuticals Breakdown Data by Application 5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2017-2022) 5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Pet Biopharmaceuticals Market Size (2017-2028) 6.2 North America Pet Biopharmaceuticals Market Size by Type 6.2.1 North America Pet Biopharmaceuticals Market Size by Type (2017-2022) 6.2.2 North America Pet Biopharmaceuticals Market Size by Type (2023-2028) 6.2.3 North America Pet Biopharmaceuticals Market Share by Type (2017-2028) 6.3 North America Pet Biopharmaceuticals Market Size by Application 6.3.1 North America Pet Biopharmaceuticals Market Size by Application (2017-2022) 6.3.2 North America Pet Biopharmaceuticals Market Size by Application (2023-2028) 6.3.3 North America Pet Biopharmaceuticals Market Share by Application (2017-2028) 6.4 North America Pet Biopharmaceuticals Market Size by Country 6.4.1 North America Pet Biopharmaceuticals Market Size by Country (2017-2022) 6.4.2 North America Pet Biopharmaceuticals Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pet Biopharmaceuticals Market Size (2017-2028) 7.2 Europe Pet Biopharmaceuticals Market Size by Type 7.2.1 Europe Pet Biopharmaceuticals Market Size by Type (2017-2022) 7.2.2 Europe Pet Biopharmaceuticals Market Size by Type (2023-2028) 7.2.3 Europe Pet Biopharmaceuticals Market Share by Type (2017-2028) 7.3 Europe Pet Biopharmaceuticals Market Size by Application 7.3.1 Europe Pet Biopharmaceuticals Market Size by Application (2017-2022) 7.3.2 Europe Pet Biopharmaceuticals Market Size by Application (2023-2028) 7.3.3 Europe Pet Biopharmaceuticals Market Share by Application (2017-2028) 7.4 Europe Pet Biopharmaceuticals Market Size by Country 7.4.1 Europe Pet Biopharmaceuticals Market Size by Country (2017-2022) 7.4.2 Europe Pet Biopharmaceuticals Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Pet Biopharmaceuticals Market Size (2017-2028) 8.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type 8.2.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Pet Biopharmaceuticals Market Share by Type (2017-2028) 8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Application 8.3.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Pet Biopharmaceuticals Market Share by Application (2017-2028) 8.4 Asia-Pacific Pet Biopharmaceuticals Market Size by Region 8.4.1 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pet Biopharmaceuticals Market Size (2017-2028) 9.2 Latin America Pet Biopharmaceuticals Market Size by Type 9.2.1 Latin America Pet Biopharmaceuticals Market Size by Type (2017-2022) 9.2.2 Latin America Pet Biopharmaceuticals Market Size by Type (2023-2028) 9.2.3 Latin America Pet Biopharmaceuticals Market Share by Type (2017-2028) 9.3 Latin America Pet Biopharmaceuticals Market Size by Application 9.3.1 Latin America Pet Biopharmaceuticals Market Size by Application (2017-2022) 9.3.2 Latin America Pet Biopharmaceuticals Market Size by Application (2023-2028) 9.3.3 Latin America Pet Biopharmaceuticals Market Share by Application (2017-2028) 9.4 Latin America Pet Biopharmaceuticals Market Size by Country 9.4.1 Latin America Pet Biopharmaceuticals Market Size by Country (2017-2022) 9.4.2 Latin America Pet Biopharmaceuticals Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pet Biopharmaceuticals Market Size (2017-2028) 10.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type 10.2.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Pet Biopharmaceuticals Market Share by Type (2017-2028) 10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Application 10.3.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Pet Biopharmaceuticals Market Share by Application (2017-2028) 10.4 Middle East & Africa Pet Biopharmaceuticals Market Size by Country 10.4.1 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Zoetis 11.1.1 Zoetis Company Details 11.1.2 Zoetis Business Overview 11.1.3 Zoetis Pet Biopharmaceuticals Introduction 11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.1.5 Zoetis Recent Developments 11.2 Boehringer Ingelheim 11.2.1 Boehringer Ingelheim Company Details 11.2.2 Boehringer Ingelheim Business Overview 11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction 11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.2.5 Boehringer Ingelheim Recent Developments 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Pet Biopharmaceuticals Introduction 11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.3.5 Merck Recent Developments 11.4 Elanco 11.4.1 Elanco Company Details 11.4.2 Elanco Business Overview 11.4.3 Elanco Pet Biopharmaceuticals Introduction 11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.4.5 Elanco Recent Developments 11.5 Virbac 11.5.1 Virbac Company Details 11.5.2 Virbac Business Overview 11.5.3 Virbac Pet Biopharmaceuticals Introduction 11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.5.5 Virbac Recent Developments 11.6 Dechra Veterinary Products 11.6.1 Dechra Veterinary Products Company Details 11.6.2 Dechra Veterinary Products Business Overview 11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction 11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.6.5 Dechra Veterinary Products Recent Developments 11.7 Ceva 11.7.1 Ceva Company Details 11.7.2 Ceva Business Overview 11.7.3 Ceva Pet Biopharmaceuticals Introduction 11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.7.5 Ceva Recent Developments 11.8 Vetoquinol 11.8.1 Vetoquinol Company Details 11.8.2 Vetoquinol Business Overview 11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction 11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.8.5 Vetoquinol Recent Developments 11.9 Ouro Fino Saude 11.9.1 Ouro Fino Saude Company Details 11.9.2 Ouro Fino Saude Business Overview 11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction 11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.9.5 Ouro Fino Saude Recent Developments 11.10 Norbrook 11.10.1 Norbrook Company Details 11.10.2 Norbrook Business Overview 11.10.3 Norbrook Pet Biopharmaceuticals Introduction 11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.10.5 Norbrook Recent Developments 11.11 Jindun 11.11.1 Jindun Company Details 11.11.2 Jindun Business Overview 11.11.3 Jindun Pet Biopharmaceuticals Introduction 11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.11.5 Jindun Recent Developments 11.12 Chopperlvya Animal Health 11.12.1 Chopperlvya Animal Health Company Details 11.12.2 Chopperlvya Animal Health Business Overview 11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction 11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.12.5 Chopperlvya Animal Health Recent Developments 11.13 CAHIC 11.13.1 CAHIC Company Details 11.13.2 CAHIC Business Overview 11.13.3 CAHIC Pet Biopharmaceuticals Introduction 11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2017-2022) 11.13.5 CAHIC Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Antiparasitic Table 3. Key Players of Biological Products Table 4. Key Players of Antibacterial Table 5. Key Players of Others Table 6. Global Pet Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 7. Global Pet Biopharmaceuticals Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Pet Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Pet Biopharmaceuticals Market Share by Region (2017-2022) Table 10. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Pet Biopharmaceuticals Market Share by Region (2023-2028) Table 12. Pet Biopharmaceuticals Market Trends Table 13. Pet Biopharmaceuticals Market Drivers Table 14. Pet Biopharmaceuticals Market Challenges Table 15. Pet Biopharmaceuticals Market Restraints Table 16. Global Pet Biopharmaceuticals Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Pet Biopharmaceuticals Revenue Share by Players (2017-2022) Table 18. Global Top Pet Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2021) Table 19. Ranking of Global Top Pet Biopharmaceuticals Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Pet Biopharmaceuticals Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pet Biopharmaceuticals Product Solution and Service Table 23. Date of Enter into Pet Biopharmaceuticals Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Pet Biopharmaceuticals Revenue Market Share by Type (2017-2022) Table 27. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2023-2028) Table 29. Global Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Pet Biopharmaceuticals Revenue Share by Application (2017-2022) Table 31. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Pet Biopharmaceuticals Revenue Share by Application (2023-2028) Table 33. North America Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 34. North America Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 35. North America Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 36. North America Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 37. North America Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 38. North America Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 39. Europe Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 40. Europe Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 41. Europe Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 42. Europe Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 43. Europe Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 44. Europe Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 45. Asia Pacific Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 46. Asia Pacific Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 47. Asia Pacific Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 48. Asia Pacific Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 49. Asia Pacific Pet Biopharmaceuticals Market Size by Region (2017-2022) & (US$ Million) Table 50. Asia Pacific Pet Biopharmaceuticals Market Size by Region (2023-2028) & (US$ Million) Table 51. Latin America Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 52. Latin America Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 53. Latin America Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 54. Latin America Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 55. Latin America Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 56. Latin America Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 57. Middle East and Africa Pet Biopharmaceuticals Market Size by Type (2017-2022) & (US$ Million) Table 58. Middle East and Africa Pet Biopharmaceuticals Market Size by Type (2023-2028) & (US$ Million) Table 59. Middle East and Africa Pet Biopharmaceuticals Market Size by Application (2017-2022) & (US$ Million) Table 60. Middle East and Africa Pet Biopharmaceuticals Market Size by Application (2023-2028) & (US$ Million) Table 61. Middle East and Africa Pet Biopharmaceuticals Market Size by Country (2017-2022) & (US$ Million) Table 62. Middle East and Africa Pet Biopharmaceuticals Market Size by Country (2023-2028) & (US$ Million) Table 63. Zoetis Company Details Table 64. Zoetis Business Overview Table 65. Zoetis Pet Biopharmaceuticals Product Table 66. Zoetis Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 67. Zoetis Recent Developments Table 68. Boehringer Ingelheim Company Details Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Pet Biopharmaceuticals Product Table 71. Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 72. Boehringer Ingelheim Recent Developments Table 73. Merck Company Details Table 74. Merck Business Overview Table 75. Merck Pet Biopharmaceuticals Product Table 76. Merck Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 77. Merck Recent Developments Table 78. Elanco Company Details Table 79. Elanco Business Overview Table 80. Elanco Pet Biopharmaceuticals Product Table 81. Elanco Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 82. Elanco Recent Developments Table 83. Virbac Company Details Table 84. Virbac Business Overview Table 85. Virbac Pet Biopharmaceuticals Product Table 86. Virbac Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 87. Virbac Recent Developments Table 88. Dechra Veterinary Products Company Details Table 89. Dechra Veterinary Products Business Overview Table 90. Dechra Veterinary Products Pet Biopharmaceuticals Product Table 91. Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 92. Dechra Veterinary Products Recent Developments Table 93. Ceva Company Details Table 94. Ceva Business Overview Table 95. Ceva Pet Biopharmaceuticals Product Table 96. Ceva Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 97. Ceva Recent Developments Table 98. Vetoquinol Company Details Table 99. Vetoquinol Business Overview Table 100. Vetoquinol Pet Biopharmaceuticals Product Table 101. Vetoquinol Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 102. Vetoquinol Recent Developments Table 103. Ouro Fino Saude Company Details Table 104. Ouro Fino Saude Business Overview Table 105. Ouro Fino Saude Pet Biopharmaceuticals Product Table 106. Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 107. Ouro Fino Saude Recent Developments Table 108. Norbrook Company Details Table 109. Norbrook Business Overview Table 110. Norbrook Pet Biopharmaceuticals Product Table 111. Norbrook Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 112. Norbrook Recent Developments Table 113. Jindun Company Details Table 114. Jindun Business Overview Table 115. Jindun Pet Biopharmaceuticals Product Table 116. Jindun Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 117. Jindun Recent Developments Table 118. Chopperlvya Animal Health Company Details Table 119. Chopperlvya Animal Health Business Overview Table 120. Chopperlvya Animal Health Pet Biopharmaceuticals Product Table 121. Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 122. Chopperlvya Animal Health Recent Developments Table 123. CAHIC Company Details Table 124. CAHIC Business Overview Table 125. CAHIC Pet Biopharmaceuticals Product Table 126. CAHIC Revenue in Pet Biopharmaceuticals Business (2017-2022) & (US$ Million) Table 127. CAHIC Recent Developments Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Global Pet Biopharmaceuticals Market Share by Type: 2021 VS 2028 Figure 2. Antiparasitic Features Figure 3. Biological Products Features Figure 4. Antibacterial Features Figure 5. Others Features Figure 6. Global Pet Biopharmaceuticals Market Share by Application: 2021 VS 2028 Figure 7. Prevention Case Studies Figure 8. Treatment Case Studies Figure 9. Pet Biopharmaceuticals Report Years Considered Figure 10. Global Pet Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Pet Biopharmaceuticals Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Pet Biopharmaceuticals Market Share by Region: 2021 VS 2028 Figure 13. Global Pet Biopharmaceuticals Market Share by Players in 2021 Figure 14. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2021 Figure 16. North America Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 17. North America Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 18. North America Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 19. North America Pet Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 20. United States Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Canada Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 23. Europe Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 24. Europe Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 25. Europe Pet Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 26. Germany Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. France Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. U.K. Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Italy Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Russia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Nordic Countries Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Asia-Pacific Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 33. Asia Pacific Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 34. Asia Pacific Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 35. Asia Pacific Pet Biopharmaceuticals Market Size Share by Region (2017-2028) Figure 36. China Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Japan Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. South Korea Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Southeast Asia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. India Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Australia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 42. Latin America Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 43. Latin America Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 44. Latin America Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 45. Latin America Pet Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 46. Mexico Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 47. Brazil Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Middle East & Africa Pet Biopharmaceuticals Market Size YoY (2017-2028) & (US$ Million) Figure 49. Middle East and Africa Pet Biopharmaceuticals Market Size Market Share by Type (2017-2028) Figure 50. Middle East and Africa Pet Biopharmaceuticals Market Size Market Share by Application (2017-2028) Figure 51. Middle East and Africa Pet Biopharmaceuticals Market Size Share by Country (2017-2028) Figure 52. Turkey Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Saudi Arabia Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. UAE Pet Biopharmaceuticals Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. Zoetis Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 56. Boehringer Ingelheim Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 57. Merck Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 58. Elanco Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 59. Virbac Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 60. Dechra Veterinary Products Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 61. Ceva Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 62. Vetoquinol Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 63. Ouro Fino Saude Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 64. Norbrook Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 65. Jindun Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 66. Chopperlvya Animal Health Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 67. CAHIC Revenue Growth Rate in Pet Biopharmaceuticals Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Zoetis Boehringer Ingelheim Merck Elanco Virbac Dechra Veterinary Products Ceva Vetoquinol Ouro Fino Saude Norbrook Jindun Chopperlvya Animal Health CAHIC